Spine
K2M’s IPO could reap as much as $183M
K2M says its forthcoming initial public offering could garner as much as $183 million, if its underwriters exercise a 1.3 million-share over-allotment.
K2M Group Holdings, the largest privately held spinal implant maker, said today that its forthcoming initial public offering could be worth up to $183 million.
K2M announced its plans for a U.S. IPO early this year, saying in March that the launch could be worth $100 million.